Key Financial Data Of Group

Oncolys BioPharma Inc. - Filing #7587326

Concept As at
2022-09-30
2022-01-01 to
2022-09-30
2022-07-01 to
2022-09-30
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-09-30
As at
2021-09-30
2021-07-01 to
2021-09-30
Key financial data of group
Business results of group
Net sales
784,509,000 JPY
642,494,000 JPY
318,317,000 JPY
Ordinary profit (loss)
-854,455,000 JPY
-1,500,888,000 JPY
-976,891,000 JPY
Net assets
2,472,958,000 JPY
3,593,992,000 JPY
4,152,227,000 JPY
Total assets
3,455,544,000 JPY
4,291,876,000 JPY
4,883,402,000 JPY
Basic earnings (loss) per share
-48.20
-15.43
-95.50
-58.42
-19.00
Diluted earnings per share
Equity-to-asset ratio
0.713 xbrli:pure
0.836 xbrli:pure
0.849 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.